Home / Tag Archives: tafinlar

Tag Archives: tafinlar

May, 2018

December, 2017

October, 2017

June, 2017

November, 2015

February, 2015

  • 6 February

    GSK Reports Positive Results from its Late-Stage Melanoma Trial

    GlaxoSmithKline (GSK) announced that its late-stage metastatic melanoma trial significantly improved overall survival (OS). The Phase III COMBI-d study evaluated the combination of the BRAF inhibitor, dabrafenib (Tafinlar), and the MEK inhibitor, trametinib (Mekinist), compared to single agent therapy with dabrafenib (Tafinlar) and placebo in patients with unresectable (Stage IIIC) …